Tag: Otsuka Pharmaceutical
Skadden advises Otsuka on potential USD1.2bn biotech buy
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
English
Skadden, Arps, Slate, Meagher & Flom is advising Tokyo-based Otsuka Pharmaceutical on its acquisition of clinical-stage biotechnology company
An unprecedented transfer of private wealth is colliding with tighter regulation and rising complexity